The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha-1 adrenergic response
Open accessAbstract
We have shown recently that norepinephrine stimulates muscle cell hypertrophy in primary cultures from the neonatal rat ventricle and that this stimulation is not blocked by the beta adrenergic antagonist propranolol. The present study was done to define the adrenergic specificity of the myocyte hypertrophic response to norepinephrine. 90% pure, single-cell cultures of nongrowing myocytes were maintained in serum-free medium 199 with transferin and insulin. Myocyte size was quantitated 48 h after addition of adrenergic agents, by measuring cell volume, cell surface area, and cell protein. L-norepinephrine increased myocyte size to a maximum 150% of control; half-maximum effect was obtained at a concentration of 0.2 microM. This increase in cell size was inhibited by the nonselective alpha adrenergic antagonist phentolamine and by the alpha 1 adrenergic antagonists prazosin and terazosin; it was not inhibited by propranolol or by the alpha 2 adrenergic antagonist yohimbine. The beta adrenergic agonist isoproterenol did not increase cell size. Thus, norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In support of this, catecholamines have been shown experimentally to have trophic properties on cardiac myocytes (35)and in the intact animal heart (36).”
From Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive (2001) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,671
Zar, J. H. (1996) · Cited by 7,837
Presynaptic regulation of the release of catecholamines.
Langer, S. Z. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06843-7 · Cited by 1,504
Simpson, P., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.50.1.101 · Cited by 453
Simpson, P. C., McGrath, A., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.51.6.787 · Cited by 429
Studies on isoproterenol-induced cardiomegaly in rats
Stanton, H. C., Brenner, G., & Mayfield, E. D. (1969) · American Heart Journal · doi:10.1016/0002-8703(69)90131-8 · Cited by 216
Östman‐Smith, I. (1981) · Clinical Science · doi:10.1042/cs0610265 · Cited by 182
MacManus, J. P., Braceland, B., Youdale, T., & Whitfield, J. F. (1973) · Journal of Cellular Physiology · doi:10.1002/jcp.1040820204 · Cited by 144
Function of myocardial α-adrenoceptors
Benfey, B. G. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90062-v · Cited by 122
Flagged first, then by citations
Research works printed but not linked: 1
- Kyncl, J. J., E. N. Bush, and S. A. Buckner. 1982. Alpha adrenergic blocking properties of terazosin. Fed. Proc. 41:1648.
Cited by
Sorted by citations
Items 301–400 of 618
Choi, S. Y., Cho, K. I., Han, Y. J., You, G. I., Kim, J., Heo, J. H., Kim, H. S., Cha, T. J., & Lee, J. (2014) · Korean Circulation Journal · doi:10.4070/kcj.2014.44.2.89 · Cited by 24
Zolk, O., Flesch, M., Schnabel, P., Teisman, A. C. H., Pinto, Y. M., van Gilst, W. H., Paul, M., & Böhm, M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701615 · Cited by 24
Schobel, H. P., Langenfeld, M. R. W., GATZKA, C., & Schmieder, R. E. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90013-7 · Cited by 24
Age-dependent changes in expression of alpha1-adrenergic receptors in rat myocardium
Schaffer, W. F., & Williams, R. S. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90293-7 · Cited by 24
Vogt, M., & Strauer, B. E. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80488-3 · Cited by 24
Drobysheva, A., Ahmad, M., White, R. A., Wang, H., & Leenen, F. H. H. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00445.2013 · Cited by 23
Changes in adrenergic receptors during the development of heart failure
Dhalla, N. S., Dixon, I., Suzuki, S., Kaneko, M., Kobayashi, A., & Beamish, R. E. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf00240302 · Cited by 23
Phosphatidylinositol and inositolphosphatide metabolism in hypertrophied rat heart.
Shoki, M., Kawaguchi, H., OKAMOTO, H., SANO, H., Sawa, H., KUDO, T., Hirao, N., SAKATA, Y., & Yasuda, H. (1992) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.56.142 · Cited by 23
Rodríguez-Feo, J. A., Fortes, J., Aceituno, E., Farré, J., Ayala, R., Castilla, C., Rico, L., González-Fernández, F., García-Durán, M., Casado, S., et al. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018030-00011 · Cited by 23
Jonsson, J. R., Head, R. J., & Frewin, D. B. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90538-f · Cited by 23
Heterotrimeric G proteins in heart disease
Schnabel, P., & Böhm, M. (1996) · Cellular Signalling · doi:10.1016/s0898-6568(96)00087-3 · Cited by 22
Lyons, D., Roy, S., O’Byrne, S., & Swift, C. G. (1997) · Circulation · doi:10.1161/01.cir.96.3.911 · Cited by 23
León, E. G. D., Voces, F., Ardanaz, N., Montero, M. J., valo, M. A., & Sevilla, M. A. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200309000-00005 · Cited by 22
Genetic mapping of quantitative trait loci influencing left ventricular mass in rats
Tsujita, Y., Iwai, N., Tamaki, S., Nakamura, Y., Nishimura, M., & Kinoshita, M. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.5.h2062 · Cited by 22
Metra, M., Nodari, S., & Cas, L. D. (2001) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200101010-00001 · Cited by 22
B�hm, M., Mende, U., Schmitz, W. L., & Scholz, H. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00512942 · Cited by 22
Catecholamines and essential hypertension
Esler, M. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80182-x · Cited by 22
Hasenfuss, G. P., & Just, H. (1994) · Heart · doi:10.1136/hrt.72.2_suppl.s10 · Cited by 22
Zhao, M., & Muntz, K. H. (1993) · Circulation Research · doi:10.1161/01.res.73.5.943 · Cited by 22
Uematsu, T., Yamazaki, T., Hiroyuki, M., Hayashi, Y., & Nakashima, M. (1989) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(89)90004-1 · Cited by 21
Carotid Vascular Remodeling in Patients with Pheochromocytoma
Bernini, G. P., Franzoni, F., Galetta, F., Moretti, A., Taurino, C., Bardini, M., Santoro, G., Ghiadoni, L., Bernini, M., & Salvetti, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2199 · Cited by 21
Theilade, J., Hansen, J. L., Haunsø, S., & Sheikh, S. P. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02701-1 · Cited by 21
Devereux, R. B. (1987) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30810-0 · Cited by 21
Chiba, K., Moriyama, S., Ishigai, Y., Fukuzawa, A., Irie, K., & Shibano, T. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13155.x · Cited by 20
Asai, T., Kushiro, T., Fujita, H., & Kanmatsuse, K. (2005) · Hypertension Research · doi:10.1291/hypres.28.79 · Cited by 20
Cigarroa, C. G., Boehrer, J. D., Brickner, M. E., Eichhorn, E. J., & Grayburn, P. A. (1992) · Circulation · doi:10.1161/01.cir.86.1.226 · Cited by 20
Sakata, K., Yoshida, H., Obayashi, K., Ishikawa, J., Tamekiyo, H., Nawada, R., & Doi, O. (2002) · Journal of Hypertension · doi:10.1097/00004872-200201000-00015 · Cited by 20
α1-Adrenoceptor subtype activation increases proto-oncogene mRNA levels. Role of protein kinase C
García-Sáinz, J. A., Alcántara-Hernández, R., & Vázquez‐Prado, J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01465-9 · Cited by 20
Role of receptor mechanisms in the adaptive response to habitual exercise
Williams, R. S. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)91057-4 · Cited by 19
RBCK1, a Protein Kinase CβI (PKCβI)-interacting Protein, Regulates PKCβ-dependent Function
Vallentin, A., & Mochly‐Rosen, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601710200 · Cited by 19
Patel, M. B. (1989) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(89)90771-2 · Cited by 19
Shakar, S. F., & Bristow, M. R. (2001) · Current Cardiology Reports · doi:10.1007/s11886-001-0027-8 · Cited by 19
Ins 1,4,5-P3 and Ca2+ signaling in quiescent neonatal cardiac myocytes
Hansen, C. A., Joseph, S. K., & Robishaw, J. D. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90289-5 · Cited by 19
Lubic, S. P., Giacomini, K. M., & Giacomini, J. C. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(95)90042-x · Cited by 19
Morimoto, S., Terada, K., Keira, N., Satoda, M., Inoue, K., Tatsukawa, H., Katoh, S., Ida, K., Sugihara, H., Takeda, K., et al. (1996) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00843703 · Cited by 18
A Farnesyltransferase Inhibitor Attenuates Cardiac Myocyte Hypertrophy and Gene Expression
Calderone, A., Abdelaziz, N., Colombo, F., Schreiber, K. L., & Rindt, H. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1150 · Cited by 18
Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects
Mulè, G., Nardi, E., Cottone, S., Cusimano, P., Incalcaterra, F., Giandalia, M. E., Palermo, A., Mezzatesta, G., & Cerasola, G. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.011 · Cited by 18
Anversa, P. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00035-1 · Cited by 18
ANTIHYPERTENSIVE DRUGS AND SYMPATHETIC NERVOUS SYSTEM
Rabbia, F., Martini, G., Genova, G. C., Milan, A., Chiandussi, L., & Veglio, F. (2001) · Clinical and Experimental Hypertension · doi:10.1081/ceh-100001201 · Cited by 18
The Sympathetic Nervous System in Congestive Heart Failure
Colucci, W. S. (1994) · Springer eBooks · doi:10.1007/978-1-4613-8315-4_8 · Cited by 18
Effects of catecholamines on fetal rat cardiocytes in vitro
Marino, T. A., Walter, R. A., D'Ambra, K., & Mercer, W. E. (1989) · American Journal of Anatomy · doi:10.1002/aja.1001860203 · Cited by 18
Prasad, A., Mahmood, A., Gupta, R., Bisoyi, P., Saleem, N., Prasad, S. V. N., & Goswami, S. K. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174350 · Cited by 17
Overview of α1-Adrenoceptor Antagonism and Recent Advances in Hypertensive Therapy
Veelken, R. A., & Schmieder, R. E. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00289-0 · Cited by 17
Zierhut, W., & Zimmer, H. (1989) · Basic Research in Cardiology · doi:10.1007/bf02650870 · Cited by 17
Gangopadhyay, J. P., & Ikemoto, N. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.129 · Cited by 16
Inhibitory effects of interferon-γ on myocardial hypertrophy
Jin, H., Li, W., Yang, R., Ogasawara, A. K., Lu, H., & Paoni, N. F. (2005) · Cytokine · doi:10.1016/j.cyto.2005.06.013 · Cited by 16
Sherwood, A., Gullette, E. C. D., Hinderliter, A. L., Georgiades, A., Babyak, M. A., WAUGH, R. A., & Blumenthal, J. A. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00007 · Cited by 16
Current Trends in the Treatment of Hypertension: A Mixed Picture
Julius, S. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00389-0 · Cited by 16
G protein‐independent stimulation of human myocardial phospholipase C by mastoparan
Schnabel, P., Gäs, H., Nohr, T., & Böhm, M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701341 · Cited by 16
Inotropic therapy of the failing myocardium
Om, A., & Hess, M. L. (1993) · Clinical Cardiology · doi:10.1002/clc.4960160103 · Cited by 16
Ventricular Remodeling: From Bedside to Molecule
Jaffe, R., Flugelman, M. Y., Halon, D. A., & Lewis, B. S. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5959-7_22 · Cited by 16
Effects of Alcohol Intake on Organ Injuries in Normotensive and Hypertensive Human Subjects
Ishimitsu, T., Yoshida, K., Nakamura, M., Tsukada, K., Yagi, S., Ohrui, M., Hisauchi, T., & Matsuoka, H. (1997) · Clinical Science · doi:10.1042/cs0930541 · Cited by 16
Nomura, S., & Komuro, I. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.11.010 · Cited by 16
Luteolin suppresses lipopolysaccharide‑induced cardiomyocyte hypertrophy and autophagy in�vitro
Li, X., Liu, J., Wang, J., & Zhang, D. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9803 · Cited by 15
Cocaine Increases β-Myosin Heavy-Chain Protein Expression in Cardiac Myocytes
Henning, R. J., Silva, J., Reddy, V., Kamat, S., Morgan, M. B., Li, Y. X., & Chiou, S. (2000) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1054/jcpt.2000.19331 · Cited by 15
β-Adrenoceptor and adenylate cyclase regulation in cardiac myocyte growth
Karliner, J. S., & Simpson, P. C. (1988) · Basic Research in Cardiology · doi:10.1007/bf01906960 · Cited by 15
Richardson, M. D., Kilts, J. D., & Kwatra, M. M. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2392 · Cited by 15
Effect of an ACE inhibitor and an AT1 receptor antagonist on cardiac hypertrophy
Shikata, C., Takeda, A., & Takeda, N. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1024109007392 · Cited by 15
O’Connor, B., Robbins, N., Koch, S. E., & Rubinstein, J. (2020) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2020.06.001 · Cited by 14
Beak, J. Y., Kang, H. S., Huang, W., Deshmukh, R., Hong, S. J., Kadakia, N., Aghajanian, A., Gerrish, K., Jetten, A. M., & Jensen, B. C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101358 · Cited by 14
α1A-Adrenergic Receptors Regulate Cardiac Hypertrophy In Vivo Through Interleukin-6 Secretion
Papay, R. S., Shi, T., Piascik, M. T., Prasad, S. V. N., & Perez, D. M. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.084483 · Cited by 14
Left ventricular hypertrophy in hypertensive patients
Leenen, F. H. H. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90133-2 · Cited by 14
Different regulation of p27 and Akt during cardiomyocyte proliferation and hypertrophy
Hinrichsen, R., Haunsø, S., Hinrichsen, R., Haunsø, S., Busk, P. K., Hinrichsen, R., Haunsø, S., & Busk, P. K. (2007) · Growth Factors · doi:10.1080/08977190701549835 · Cited by 14
Podgórska, M., Kocbuch, K., Grdeń, M., Szutowicz, A., & Pawełczyk, T. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0578-8 · Cited by 14
Zolk, O. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00081-9 · Cited by 14
Clark, W. A., Rudnick, S. J., Andersen, L. C., & LaPres, J. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47286-9 · Cited by 14
Some Thoughts on Pathogenesis, Therapy and Prevention of Hypertension
Korner, P. I. (1994) · Blood Pressure · doi:10.3109/08037059409101516 · Cited by 14
Kolbeck-Rühmkorff, C., & Zimmer, H. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(08)80045-4 · Cited by 14
Inositol phosphates in the heart: controversy and consensus
Woodcock, E. A. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00231618 · Cited by 14
Differential effects of Pyk2 and FAK on the hypertrophic response of cardiac myocytes
Menashi, E., & Loftus, J. C. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0807-9 · Cited by 13
Giles, T. D., Sander, G. E., THOMAS, M., & Quiroz, A. C. (1986) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(86)80459-x · Cited by 13
Early and Late Sympathetic Activation in Hypertension
Mancia, G., Rienzo, M. D., Giannattasio, C., Parati, G., & Grassi, G. M. (1998) · Scandinavian Cardiovascular Journal · doi:10.1080/140174398427992 · Cited by 13
Adrenergic hormones and control of cardiac myocyte growth
Simpson, P. C., Kariya, K., Karns, L. R., Long, C. S., & Karliner, J. S. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3886-8_5 · Cited by 13
Steensgaard-Hansen, F., & Carlsen, J. E. (1988) · Drugs · doi:10.2165/00003495-198800367-00013 · Cited by 13
Rosenkranz, S., Nickenig, G., Flesch, M., Cremers, B., Schnabel, P., Lenz, O., Krause, T., Ganten, D., Hoffmann, S., & Böhm, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00161-1 · Cited by 13
Katat, A. A., Zhao, J., Calderone, A., & Parent, L. (2022) · Cells · doi:10.3390/cells11020188 · Cited by 12
Norepinephrine‐induced cardiac hypertrophy of the cat heart
Marino, T. A., Cassidy, M., Marino, D. R., Carson, N. L., & Houser, S. R. (1991) · The Anatomical Record · doi:10.1002/ar.1092290411 · Cited by 12
Clinical implications of pathophysiologic changes in the midlife hypertensive patient
Julius, S. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90807-t · Cited by 12
Clinical Consequences of the Autonomic Imbalance in Hypertension and Congestive Heart Failure
Julius, S. (1998) · Scandinavian Cardiovascular Journal · doi:10.1080/14017439850140300-1 · Cited by 12
Moser, L., Faulhaber, J., Wiesner, R. J., & Ehmke, H. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00685.2001 · Cited by 12
Galinier, M., Sénard, J., Valet, P., Dréan, G., Planat‐Benard, V., Arias, A., Tran, M. A., & Montastruc, J. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14256.x · Cited by 12
Suzuki, J., Ohno, I., Nawata, J., Miura, S., Ikeda, J., & Shirato, K. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199911000-00003 · Cited by 12
Sampson, M., Denver, E., Foyle, W.-J., Dawson, D. K., Pinkney, J. H., & Yudkin, J. S. (1995) · Diabetologia · doi:10.1007/bf00410283 · Cited by 12
Tanaka, H., Obata, H., & Haneda, T. (1991) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.55.1233 · Cited by 12
Differential therapy of hypertensive heart disease
Motz, W., & Strauer, B. E. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90962-z · Cited by 12
Makita, N., & Yasuda, H. (1990) · Basic Research in Cardiology · doi:10.1007/bf01931489 · Cited by 12
Grosman‐Rimon, L., Wright, E., Sabovich, S., Rimon, J., Gleitman, S., Sudarsky, D., Lubovich, A., Gabizon, I., Lalonde, S. D., Tsuk, S., et al. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10232-y · Cited by 11
Classic Studies of Cultured Cardiac Myocyte Hypertrophy
Glembotski, C. C. (2013) · Circulation Research · doi:10.1161/circresaha.113.302490 · Cited by 11
Increased Cardiac Angiotensin II Receptors in Angiotensinogen-Deficient Mice
Sumida, Y., Umemura, S., Tamura, K., Kihara, M., KOBAYASHI, S., Ishigami, T., Yabana, M., Nyui, N., Ochiai, H., Fukamizu, A., et al. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.45 · Cited by 11
Zhu, L., Fang, N., Gao, P., Jin, X., Hai-ya, W., & Liu, Z. (2015) · Current Vascular Pharmacology · doi:10.2174/1570161112666141014150007 · Cited by 11
Causes and consequences of sympathetic overactivity in hypertension
Shlyakhto, E. V., & Conrady, A. Ο. (2003) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2003-9-3-81-88 · Cited by 11
Ferrans, V. J., & Rodriguez, E. (1987) · PubMed · Cited by 11
Qvigstad, E., Sjaastad, I., Bøkenes, J., Schiander, I. G., Solberg, L., Sejersted, O. M., Osnes, J., & Skomedal, T. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.027 · Cited by 11
Cardiac involvement in hypertension
DiPette, D. J., & Frohlich, E. D. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91108-3 · Cited by 11
Leman, R. B., Spinale, F. G., Dorn, G. W., Cooper, G., Spann, J. F., Gillette, P. C., & Carabello, B. A. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90307-0 · Cited by 11
Polyphosphoinositide metabolism in hypertrophic rat heart
Kawaguchi, H. (1992) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(92)91866-4 · Cited by 11
Testa, A., Mallamaci, F., Macrì, R., Pisano, A., Spoto, B., Malatino, L., Stancanelli, B., Tripepi, G. L., Benedetto, F. A., & Zoccali, C. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833bd21b · Cited by 10
Yang, M., Jiang, X., Wang, L., Cui, D., Zhang, J., Wang, X., Feng, H., Zhang, K., Zhang, K., Li, J., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/8129512 · Cited by 10
Benoît, M.-J., Rindt, H., & Allen, B. G. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-123 · Cited by 10
Li, Z., Liu, N., Zhang, L., Gong, K., Cai, Y.-B., Gao, W. D., Liu, Z., Liu, S., Han, Q., & Zhang, Y. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900029 · Cited by 10
Metadata
- Authors
- Simpson, P.
- Affiliations
- San Francisco VA Medical Center (US)
- Corresponding author
- Simpson, P
- ORCID
- Simpson, P
- Venue
- Journal of Clinical Investigation
- Published
- 1983-08-01
- Volume
- 72
- Issue
- 2
- Pages
- 732-738
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1129233
- OpenAlex
- W2110889457
- Cited by
- 618
- References
- 20
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 3 · 2013: 10 · 2012: 6
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL031113)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- norepinephrine, cardiac hypertrophy, alpha1-adrenoceptors, alpha-blockers, phentolamine, prazosin, terazosin, yohimbine, isoproterenol, propranolol
- MeSH terms
- Adrenergic alpha-Antagonists, Animals, Cardiomegaly, Isoproterenol, Myocardium, Norepinephrine, Phentolamine, Prazosin, Propranolol, Receptors, Adrenergic, Receptors, Adrenergic, alpha, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review